Preprint · CC-BY
via OpenAlex
Senolytic therapy to modulate the progression of Alzheimer’s Disease (SToMP-AD) – Outcomes from the first clinical trial of senolytic therapy for Alzheimer's disease
Miranda E. Orr, Mitzi M. Gonzales, Valentina R. Garbarino, Tiffany F. Kautz, Juan Pablo Palavicini, Marisa Lopez‐Cruzan, Shiva Kazempour Dehkordi, Julia Mathews, Habil Zare, Peng Xu, Bin Zhang, Crystal Franklin, Mohamad Habes, Suzanne Craft, Ronald C. Petersen
Research Square · 2023 · ▲ 37 citations
Abstract
This 2023 Research Square paper presents results from the first clinical trial of senolytic therapy for the treatment of Alzheimer’s disease.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.21203/rs.3.rs-2809973/v1
- Canonical
- link ↗
- Fetched
- 2026-06-15 MST
Cite this
APA
Orr, M.E., Gonzales, M.M., Garbarino, V.R., Kautz, T.F., Palavicini, J.P., Lopez‐Cruzan, M., Dehkordi, S.K., Mathews, J., Zare, H., Xu, P., Zhang, B., Franklin, C., Habes, M., Craft, S., Petersen, R.C., Tchkonia, T., Kirkland, J.L., Salardini, A., Seshadri, S., & Musi, N. (2023). Senolytic therapy to modulate the progression of Alzheimer’s Disease (SToMP-AD) – Outcomes from the first clinical trial of senolytic therapy for Alzheimer's disease. <em>Research Square</em>. https://doi.org/10.21203/rs.3.rs-2809973/v1
Vancouver
Orr ME, Gonzales MM, Garbarino VR, Kautz TF, Palavicini JP, Lopez‐Cruzan M, et al. Senolytic therapy to modulate the progression of Alzheimer’s Disease (SToMP-AD) – Outcomes from the first clinical trial of senolytic therapy for Alzheimer's disease. Research Square. 2023. doi:10.21203/rs.3.rs-2809973/v1.
BibTeX
@unpublished{miranda2023Senoly,
title = {Senolytic therapy to modulate the progression of Alzheimer’s Disease (SToMP-AD) – Outcomes from the first clinical trial of senolytic therapy for Alzheimer's disease},
author = {Miranda E. Orr and Mitzi M. Gonzales and Valentina R. Garbarino and Tiffany F. Kautz and Juan Pablo Palavicini and Marisa Lopez‐Cruzan and Shiva Kazempour Dehkordi and Julia Mathews and Habil Zare and Peng Xu and Bin Zhang and Crystal Franklin and Mohamad Habes and Suzanne Craft and Ronald C. Petersen and Tamar Tchkonia and James L. Kirkland and Arash Salardini and Sudha Seshadri and Nicolas Musi},
journal = {Research Square},
year = {2023},
doi = {10.21203/rs.3.rs-2809973/v1},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
The Lancet 2021
Preprint · OA
Alzheimer's disease
Handbook of clinical neurology 2019
Citation only
Alzheimer's disease
Nature Reviews Neurology 2024
Preprint · OA
Is Alzheimer disease a disease?
Metabolic Brain Disease 2021
Citation only
Metabolic disorder in Alzheimer’s disease
Nature Reviews Neurology 2013
Preprint · OA
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
Molecular Neurobiology 2012
Citation only